4/2006
vol. 44
Original article Correlation of neuroradiological, electroencephalographic and clinical findings in cortical dysplasias in children
Maria Mazurkiewicz-Bełdzińska
,
Folia Neuropathol 2006; 44 (4): 314–318
Online publish date: 2006/12/07
Get citation
Introduction
Cortical dysplasia (CD) is a cortex development disorder associated with abnormal cellular proliferation, cellular migration or cortical organization during foetal growth [7]. This process occurs between the 8th and 16th week of intrauterine life. Cerebral cortex malformations may be genetically determined, e.g. chromosomal (ring-X, microdeletion 17p 13.3), gene mutations (autosomal, X-linked), they may be a consequence of detrimental exogenic factors that occur during development (intrauterine CMV infection, intrauterine blood circulation disturbances), or they may be unknown. As a result, subependymal primitive neuroblasts, primarily localized in the medial line, migrate pathologically and initiate the abnormal infolding that creates malformed sulci and gyri of the cortex. CD is the most common developmental disorder in patients with pharmacoresistant epilepsy. Some authors indicate that the prevalence of refractory epilepsy in this group of patients reaches 76% [4]. Moreover, abnormalities of the cerebral gyri are frequently associated with mental retardation, focal neurological deficits and other specific systemic features. According to the classification, cortical malformations include: diffuse dysplasias (e.g. agyria, pachygyria, lissencephaly), bilateral cortical dysplasias (e.g. schizencephaly), focal (e.g. heterotopias) and hemispheric dysplasias (Table I).
There are some neurological syndromes particularly associated with cortical dysplasia presence. Among these are the following: Dandy-
-Walker syndrome (focal cortical dysplasias, heterotopias), Miller-Dieker syndrome (lissencephaly, agyria, pachygyria), Walker-Warburg syndrome (lissencephaly, agyria), etc [2].
Classification schemas and diagnosis of CD is based on the combination of neuropathological, aetiological and radiological findings. Accessibility to magnetic resonance imaging (MRI) has allowed neuronal migration deficits to be identified in an increasing number of patients. This has also allowed radiological features to be associated with epileptic seizure presence and other neurological deficits. In accordance with this, the purpose of our study was to assess the correlation between the severity of clinical and electroencephalographic findings with the neuroradiological picture of patients with CD.
Materials and methods
Patients
46 patients with the presence of CD features in MRI were identified. They were hospitalized at the Department of Developmental Neurology at the Medical University of Gdańsk (Poland) in years
2000–2005. There were 18 females and 28 males. The age ranged from 3 months to 12 years (mean age = 6.2 years, median age = 3.1 years). The objectives of the study were explained to the parents or legal representatives of children when possible and also informed consent was obtained.
Methods
Every patient was assessed according to the neurological symptoms present, which included: (1) motor function, especially presence of cerebral palsy, (2) vision and hearing disability, (3) focal neurological deficits, (4) mental retardation, (5) presence of epileptic seizures.
According to the findings mentioned above, clinical disability scores were estimated: normal – 0, mild impairment – 1, severe impairment – 2. On the basis of the clinical features (medical history and neurological examination), the child underwent comprehensive evaluation including EEG and MRI of the brain.
EEG recordings were also divided into classes: when they were normal they were classified as score 1, when abnormal background activity was found – score 1, when the presence of ictal or interictal epileptiform activity was present – score 2.
In the MRI examination, the following sequences were acquired: transverse double-echo spin-echo of the entire brain; T1-weighted coronal inversion recovery (IR), T2-weighted coronal turbo spin-echo (TSE) and T2-weighted coronal TSE fluid-attenuated inversion recovery (FLAIR). The MR data were reviewed by a neuroradiologist. The following characteristics were specifically looked for on each patient’s MR images: gyration anomalies, focal thickenings of the cortex, increased signal intensity of grey matter and subcortical white matter, blurring of the grey-white matter junction, focal brain hypoplasia and shrinkage of the white matter core.
On the basis of these characteristics, we assigned each of the 46 patients to one of three categories: mild changes (restricted) – score 1, moderate changes (not restricted) – score 2, and severe changes – score 3.
Statistical analyses
Statistical analysis of the data was performed with Statistica® 6.0 for Windows® and Microsoft Excel®.
Chi--square analyses were used for discrete data and Fisher exact test for analysis of 2 x 2 tables with small frequencies. For continuous variables, comparisons of two independent groups were performed using the Student t-test, when distributions were normal or approximately normal, and the Mann-Whitney test, the nonparametric counterpart of the t-test, when distributions were skewed. For multivariate analysis logistic regression was performed. Spearman’s correlation was used to assess the strength of the relationship between the pairs of the variables. P<0.05 was considered statistically significant.
Results
MRI review
There were a total of 46 patients with radiologically confirmed diagnosis of CD. The main characteristics of MRI findings are presented in Table III.
The localization of the cerebral cortex malformations was: temporal (24), extratemporal (10) and multilobar (12). However, approximately one-quarter of cases had more diffuse structure.
Regarding MRI scores: There were 10 patients (22%) included in the first (score 1), 25 (54%) in the second (score 2) and 11 (24%) in the third category (score 3).
Electroencephalographic findings
The mean age of seizure onset was 14 months and the mean duration of epilepsy was 3.5 years (ranged from 3 months to 7 years). The mean seizure frequency was 8 per month.
Of the entire group, 37 (80%) suffered from active epilepsy and in 28 cases (60%) seizures were pharmacoresistant.
Performed surface electroencephalography (EEG) revealed a normal record in 11 (25%) cases. Nonetheless, in the majority of patients (35; 75%) EEG records demonstrated abnormalities, such as pathological background (28; 60%), interictal (27; 59%) or ictal epileptiform activity (30; 65%). In all “ictal” cases the EEG alterations correlated with localization of CD. Severity of EEG changes, described according to the 3-score system, were assessed in each of the following age groups: below 1st year of life, between 1 to 5 years, and more than 5 years. The analysis has shown that the highest severity of changes strongly correlated with the age of onset below 1 year (Fig. 1).
The electroencephalographic and imaging characteristics revealed that there was no specific correlation between refractory epilepsy occurrence and the severity of MRI changes (Fig. 2).
Clinical functions
14 of the study patients (30%) demonstrated neurological deficits (including cerebral palsy) and 34 (74%) presented mental retardation.
The clinical state of each patient was estimated according to symptoms or deficits he or she presented (Table IV). On the basis of examination results, the severity of clinical disability was classified into one of the 3 following categories. There were
11 (24%) patients with no deviation in clinical functions (neurological and mental) (score 0), patients with mild impairment – 26 (56%) (score 1), and 9 (20%) with severe impairment (score 2). The relationship between the clinical disability score and MRI lesions was not statistically significant (Fig. 3).
The comprehensive evaluation of the MRI changes, motor disability, presence of seizures and mental retardation revealed no correlation between CD presence and features mentioned above (Spearman’s correlation; Table V).
Discussion
The study directly assessed electroencephalographic and clinical features in paediatric patients with neuroradiologically confirmed CD. In this research we conducted recommended MRI acquisition techniques and sequences for older and younger (below 2 years) children, whose white matter is either immature or marginally mature [7]. The same refers to the EEG evaluation. All the conclusions were based on the integral assessment of clinical findings, including neuropsychological tests, EEG data and MRI features. In controversial or unclear cases, further procedures were performed in order to exclude different causes of brain damage. Only distinct neuroradiological CD features were included in the study.
It has been proved that epilepsy is present or will develop in the majority of patients with CD and
in about two-thirds of cases the seizures will be pharmacoresistant. Our results also unequivocally suggest that there is a strong relationship between localization of cerebral cortex malformations and severe localized changes in the EEG in a group of patients with active epilepsy. These conclusions are in agreement with previous reports that showed straight dependence of CD on refractory epilepsy [9]. However, the severity of CD does not play a role in the severity of epilepsy.
A complex assessment indicates that mental retardation and neurological deficits are expected clinical findings in cases of cortex abnormalities. 74% of the children in the study group had been classified as mentally retarded, and only 30% demonstrated a neurological deficit. This probably reflects the phenotypic heterogeneity of CD, and reiterates the fact that some patients with these disorders are neurologically or sometimes cognitively unimpaired.
Our study demonstrated no specific correlation between the simultaneous neuroradiological, electroencephalographic and clinical abnormalities. We did not find a relationship between neurodevelopmental outcome and extent of our patients’ malformations, which is not in agreement with previous authors [10] who have shown that children with diffuse malformations were more clinically disabled than those with focal abnormalities. It agrees with their statement that there were no certain abnormalities in EEG patterns that apply to children with diffuse CD and severe clinical disability.
The weakness of this study was the inability to perform neuropathological work because of the lack of surgical treatment in this particular group of patients.
Patients with CD represent a heterogeneous group. This study proves that children with mental retardation and presence of intractable epilepsy pose a particular challenge for interdisciplinary diagnosis and treatment. Different age at epilepsy onset and transient responsiveness to antiepileptic drugs may reflect different dynamics in epileptogenicity of the underlying CD. It will be interesting to see the neuropsychological development and the course of epilepsy in this particular group of patients after some years, possibly in some of them already after epilepsy surgery.
References
1. Antel SB, Bernasconi A, Bernasconi N, Collins DL, Kearney RE, Shinghal R, Arnold DL. Computational models of MRI characteristics of focal cortical dysplasia improve lesion detection. Neuroimage 2002; 17: 1755–1760.
2. Clark GD. The classification of cortical dysplasias through molecular genetics.Brain Devt 2004; 26: 351–362.
3. Colombo N, Tassi L, Galli C, Citterio A, Lo Russo G, Scialfa G, Spreafico R. Focal cortical dysplasias: MR imaging, histopathologic, and clinical correlations in surgically treated patients with epilepsy. AJNR Am Neuroradiol 2003; 24: 724–733.
4. Fauser S, Schulze-Bonhage A, Honegger J, Carmona H, Huppertz HJ, Pantazis G, Rona S, Bast T, Strobl K, Steinhoff BJ, Korinthenberg R, Rating D, Volk B, Zentner J. Focal cortical dysplasias: surgical outcome in 67 patients in relation to histological subtypes and dual pathology. Brain 2004; 127: 2406–2418.
5. Marusic P, Najm IM, Ying Z, Prayson R, Rona S, Nair D, Hadar E, Kotagal P, Bej MD, Wyllie E, Bingaman W, Luders H. Focal cortical dysplasias in eloquent cortex: functional characteristics and correlation with MRI and histopathologic changes. Epilepsia 2002; 43: 27–32.
6. Palmini A, Najm I, Avanzini G, Babb T,Guerrini R, Foldvary-
-Schaefer N, Jackson G, Luders HO, Prayson R, Spreafico R, Vinters HV. Terminology and classification of the cortical dysplasias. Neurology 2004; 62 (6 Suppl 3): S2–S8.
7. Paciorkowski AR, Lerer T, Brunquell PJ. Structure-function correlations in patients with malformations of cortical development. Epilepsy Behav 2002; 3: 266–274.
8. Ruggieri PM, Najm I, Bronen R, Campos M, Cendes F, Duncan JS, Weiser HG, Theodore WH. Neuroimaging of the cortical dysplasias. Neurology 2004; 62 (6 Suppl 3): S27–S29.
9. Sasaki K, Ohsawa Y, Sasaki M, Kaga M, Takashima S, Matsuda H. Cerebral cortical dysplasia: assessment by MRI and SPECT. Pediatr Neurol 2000; 23: 410–415.
10. Widdess-Walsh R, Kellinghaus C, Jeha L, Kotagal P, Prayson R, Bingaman W, Najm IM. Electro-clinical and imaging characteristics of focal cortical dysplasia: correlation with pathological subtypes. Epilepsy Res 2005; 67: 25–33.
Copyright: © 2006 Mossakowski Medical Research Centre Polish Academy of Sciences and the Polish Association of Neuropathologists. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License ( http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
|
|